89
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis

, , , , , & show all
Pages 161-171 | Received 02 Sep 2004, Accepted 17 Dec 2004, Published online: 03 Oct 2008

References

  • Adnyana IK, Tezuka Y, Awale S, Banskota AH, Tran KQ, Kadota S. 2000. Quadranosides VI-XI, six new triterpene glucosides from the seeds of Combretum quadrangulare. Chem Pharm Bull (Tokyo) 48:1114–1120.
  • Asres K, Bucar F, Edelsbrunner S, Kartnig T, Hoger G, Thiel W. 2001. Investigations on antimycobacterial activity of some Ethiopian medicinal plants. Phytother Res 15:323–326.
  • Basu, MK. 1994. Liposomes in drug targeting. Biotechnol Genet Eng Rev 12:383–408.
  • Bazile DV, Ropert C, Huve P, Verrecchia T, Marlard M, Frydman A, Veillard M, Spenlehauer G. 1992. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13:1093–1102.
  • Bessey OA, Lowry OH, Brock M. 1946. A method for rapid determination of alkaline phosphatase with five cubic millimetres of serum. J Biol Chem 164:321–329. Cited in: Bergmeyer, HY., editor, Methods of enzymatic analysis, Vol. 1. 2nd ed. New York: Academic Press. pp. 221–288.
  • Cauchetier E, Paul M, Rivolet D, Fessi H, Astier A, Deniau M. 2003. Therapeutic evaluation of free and nanocapsule-encapsu- lated atovaquone in the treatment of murine visceral leishma- niasis. Ann Trop Med Parasitol 97:259–268.
  • Das N, Mahato SB, Naskar K, Ghosh DK, Basu MK. 1990. Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis. Biochem Med Metab Biol 43:133–139.
  • Durand R, Paul M, Rivollet D, Fessi H, Houin R, Astier A, Deniau M. 1997. Activity of pentamidine-loaded poly(D,L-lactide) nanoparticles against Leishmania infantum in a murine model. Parasite 4:331–336.
  • Espuelas MS, Legrand P, Loiseau PM, Bories C, Barratt G, Irache JM. 2002. In vitro antileishmanial activity of amphotericin B loaded in poly(epsiloncaprolactone) nanospheres. J Drug Target 10:593–599.
  • Galaev IY, Mattiasson B. 1999. Smart polymers and what they could do in biotechnology and medicine. Trends Biotechnol 17:335–340.
  • Gaur U, Sahoo SK, De TK, Ghosh PK, Maitra AN, Ghosh PK. 2000. Biodistribution of flouresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 202:1–10.
  • Guerrero DQ, Allemann E, Fessi H, Doelker E. 1998. Preparation, techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 24:1113–1128.
  • Gupta AK, Madan S, Majumdar DK, Maitra A. 2001. Ketorolac entrapped in polymeric nanogels: Preparation, characterization and ocular anti-inflammatory studies. Int J Pharm 209:1–14.
  • Gurr E. 1962. Staining animal tissues: Practical and theoretical. London, UK: Leonard Hill.
  • Guterres SS, Fessi H, Barratt G, Devissaguet JP. 1995. Poly (DL- lactide) nanopcapsules containing diclofenac: I. Formulation and stability study. Int J Pharm 113:57–63.
  • Kreuter J. 1996. Nanoparticles and microparticles for drug and vaccine delivery. J Anat 189:503–505.
  • Lala S, Pramanick S, Mukhopadhyay S, Bandyopadhyay S, Basu
  • MK. 2004. Harmine: Evaluation of its antileishmanial properties in various delivery systems. J Drug Target 12:165–175.
  • Liu Z, Rimmer S. 2002. Synthesis and release of 5FU from poly (N- vinylpyrrolidinone) bearing 5-FU derivatives. J Control Rel 81:91–99.
  • Lockman PR, Mumper RJ, Khan MA, Allen DD. 2002. Nanoparticle technology for drug delivery across the blood brain barrier. Drug Dev Ind Pharm 28:1–13.
  • Looker DL, Bereus RL, Marr JJ. 1983. Purine metabolism in Leishmania donovani amastigotes and promastigotes. Mol Biochem Parasitol 19:15–28.
  • Majhi PR, Moulik SP. 1999. Microcolorimetric investigations of AOT selfassociation in oil and state of pool water in water/oil microemulsions. J Phys Chem B 103:5977–5983.
  • Mitra S, Maitra AN. 2002. Nanoparticulate carriers in drug delivery and targeting. Proc Indian Natl Sci Acad B 68:349–360.
  • Moulik SP, De GC, Panda AK, Bhowmick BB, Das AR. 1999. Dispense molecular aggregates, 1. Synthesis and characterization of nanoparticles of Cu2[Fe(CN)6] in H2O/AOT/n-Heptane water- in-oil microemulsion media. Langmuir 15: 8361–8365.
  • Nandy AK, Podder G, Sahu NP, Mahato SB. 1989. Triterpenoids and their glycosides from Terminalia bellerica. Phytochem 28:2769–2772.
  • Norman ME, Williams P, Illum L. 1992. Human serum albumin as a probe for surface conditioning (opsonization) to block copolymer coated microspheres. Biomaterials 13:841–849.
  • Paul M, Durand R, Boulard Y, Fusai T, Fernandez C, Rivollet D, Deniau M, Astier A. 1998. Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: Impli- cation in the intracellular drug release in Leishmania major infected mice. J Drug Target 5:481–490.
  • Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 28:56–63. Giulbault, GG., editor, Handbook of enzymatic methods of analysis, New York and Basel: Marcel Dekker, Inc. 1976. pp. 121– 123.
  • Rosiak JM, Yoshii F. 1999. Hydrogels and their medical applications. Nucl Instrum Methods Phys Res Sec B 151:56–64. Sakuma S, Hayashi M, Akashi M. 2001. Design of nanoparticles composed of graft co-polymers for oral peptide delivery. Adv Drug Deliv Rev 47:21–37.
  • Sarkar S, Mandal S, Sinha J, Mukhopadhyay S, Das N, Basu MK. 2003. Quercetin: Critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes. J Drug Target 10:573–578.
  • Seyler I, Morin C, Barratt G, Appel M, Devissaguet JP, Puisieux F. 1995. Induction of macrophage NO-synthase by an immuno- modulator entrapped within polymeric nanocapsules. Eur J Pharm Biopharm 41:49–54.
  • Singh DV, Verma RK, Gupta MM, Kumar S. 2002. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal 13:207–210.
  • Sinha J, Raay B, Das N, Medda S, Garai S, Mahato SB, Basu MK. 2002. Bacopasaponin C: Critical evaluation of antileishmanial properties in various delivery modes. Drug Deliv 9:55–62.
  • Stauber LA, Franchino E, Grun J. 1958. An eight day method for screening compounds against Leishmania donovani in golden hamster. J Protozool 5:263–273.
  • Torchilin VP, Trubetskoy VS. 1995. Which polymers can make nanoparticulate drug carriers long circulating? Adv Drug Deliv Rev 16:141–155.
  • Torres-Santos EC, Rodrigues JM, Jr, Torres-Santos EC, Moreira DL, Kaplan MA, Rossi-Bergmann B. 1999. Improvement of in vitro and in vivo antileishmanial activities of 20,60 -dihydroxy- 40 methoxychalcone by entrapment in poly(D,L-lactide) nano- particles. Antimicrob Agents Chemother 43:1776–1778.
  • Vijayanathan V, Thomas T, Thomas TJ. 2002. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochem 41:4085–4094.
  • Young MC, Araujo QAR, daSilva CA, Lopes MN, Trevisan LM, Bolzani VS. 1998. Triterpenes and saponins from Rudgea viburnioides. J Nat Prod 61:936–938.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.